Montek (Sodium Molybdate (99mo))

Sodium molybdate, the active ingredient in Montek, is a mineral supplement presented as an injectable solution for intravenous and ocular use. It supplies molybdenum, an essential trace element that supports the activity of several enzymes involved in metabolism. GNH USA supplies Montek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Montek (sodium molybdate) is used in clinical settings that require molybdenum supplementation or diagnostic assistance. - Molybdenum deficiency: restores normal enzyme function in patients with documented deficiency. - Ocular diagnostic procedures: serves as an adjunct in certain eye imaging techniques. - Metabolic support: provides molybdenum cofactor for enzymes in patients with specific metabolic disorders.

Sodium molybdate may be associated with adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools occurring shortly after administration. - Abdominal pain: cramping or discomfort in the stomach region. - Headache: transient mild headache. - Metallic taste: transient alteration in taste perception. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Liver enzyme elevation: indicating possible hepatic stress. - Kidney dysfunction: impaired renal function in susceptible individuals.

When using Montek, clinicians should observe several safety measures. - Monitor serum molybdenum levels: ensure concentrations remain within therapeutic range. - Assess renal function: adjust use in patients with impaired kidney function. - Evaluate for hypersensitivity: discontinue if allergic reactions occur. - Use caution in pregnancy: limited data, weigh potential benefits against risks. - Avoid in known molybdenum allergy: contraindicated for individuals with prior reactions. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Potential drug interactions with sodium molybdate should be considered.

Major Interactions (Avoid): - High‑dose copper supplements: antagonistic effect reducing copper absorption. - Certain chelating agents: may bind molybdate and diminish efficacy.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may affect gastrointestinal absorption. - Diuretics: alter renal excretion of molybdenum. - Vitamin B12 therapy: theoretical competition for cellular uptake pathways.